Absci Corp. (ABSI): רווח נקי למניה (EPS TTM)

The daily chart of the rolling 12-month EPS for Absci (ABSI) on the GURU.Markets platform illustrates current capital dynamics, where -0.81 reflects the latest metric value. Contracts with pharma behemoths for generative AI are driving this growth. The model relies on external partners for live testing while maintaining algorithm protection. The high scalability of the digital workshop enables the rapid creation of antibodies and their monetization through licenses.

Earnings per share (EPS TTM) measures the issuer's bottom-line income allocated to a single common share over a year, allowing for an assessment of real business efficiency regardless of the total shares outstanding. By analyzing the EPS TTM fundamental metric, an investor can track the profit trajectory of Absci (ABSI), which in the AI-biotech sector is critically dependent on venture capital inflows and the terms of partnership agreements.